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Background: Plasmodium vivax re-emerged in 1993. Although the number of infections has been steadily
decreasing, it is likely to continue to affect public health until it is eradicated. The aim of this study is to measure
anti-circumsporozoite protein (CSP) antibody and compare malaria prevalence. As to understand the prevalence, an
epidemiology study has to be conducted in the Republic of Korea.
Methods: A total of 1,825 and 1,959 blood samples were collected in 2010 and 2011, respectively, from the
inhabitants of Ganghwa and Cheorwon counties. The antibody titers of the inhabitants were measured by
enzyme-linked immunosorbent assay (ELISA) using recombinant protein purified from Escherichia coli transformed
with a CSP gene-inserted pET-28a(+) expression vector. Microscopic examination was performed to identify malaria
parasites.
Results: The annual parasite incidence (API) in Ganghwa decreased from 4.28 in 2010 to 2.23 in 2011, and that in
Cheorwon decreased from 1.88 in 2010 to 1.15 in 2011. The antibody-positive CSP rate in these areas also decreased
from 18.14% (331/1825) in 2010 to 15.36% (301/1959) in 2011. Pearson analysis showed a strong correlation
between the API and the antibody-positive CSP rate in these areas (r = 1.000, P < 0.01). The intensity of the immune
responses of the inhabitants of Cheorwon, as measured by the mean optical density, decreased from 0.9186 ± 0.0472 in
2010 to 0.7035 ± 0.0457 in 2011 (P = 0.034), but increased in Ganghwa from 0.7649 ± 0.0192 in 2010 to 0.8237 ± 0.1970
in 2011 (P = 0.006). The immune response increased according to age (r = 0.686, P = 0.041).
Conclusions: The positive CSP-ELISA rate was closely related to the API in the study areas. This suggests that
seroepidemiological studies based on CSP-ELISA may be helpful in estimating the malaria prevalence. Moreover,
such studies can be used to establish and evaluate malaria control and eradication programmes in high-risk areas in Korea.* Correspondence: tongsookim@inha.ac.kr; rainlee67@naver.com
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Plasmodium vivax is the causative agent of relapsing be-
nign tertian human malaria, the second most common
type of human malaria, and it afflicts several hundred
million individuals annually. This disease is a major pub-
lic health problem in most tropical regions and many
temperate countries, including the Democratic People’s
Republic of Korea (DPRK) and the Republic of Korea
(ROK) [1].
The first scientific documentation of malaria occurrence
was published in 1913, although malaria had been preva-
lent throughout the Korean peninsula for several centu-
ries [2]. As a result of a national malaria eradication
programme conducted in cooperation with the World
Health Organization, the incidence of vivax malaria in
ROK has rapidly decreased [3,4]. In fact, vivax malaria
was thought to have been eradicated in ROK in the late
1970s until two sporadic cases were detected in the 1980s
[5]. In 1993, one case was diagnosed in an ROK soldier
serving in northern Gyeonggi province [6], and Cho et al.
subsequently reported cases in two infected civilians [7].
Thereafter, many cases were reported near the demilitar-
ized zone (DMZ), which centres on Paju-si, Yeoncheon-
gun, Cheorwon-gun, Gimpo-si, Ganghwa-gun, Goyang-si,
and Dongducheon-si. There is now considerable concern
that malaria will become re-established in the region and
then expand to other geographical areas [8].
Parasitaemia provides the basis for the classical method
of measuring the endemicity of malaria. However, using
data on only the incidence of parasitaemia may be insuffi-
cient to adequately determine the epidemiology of malaria
in a given population. For example, when the incidence of
malaria is low, mass blood surveys do not yield results
commensurate with the work involved [9,10]. Serological
surveys have provided valuable epidemiological informa-
tion, especially in areas of low endemicity [11,12]. Interest-
ingly, most patients with malaria in ROK show a long
incubation period [13]. It is thought that a long incubation
period is associated with sporogonic parasites; thus, cir-
cumsporozoite protein (CSP) was selected for the present
seroepidemiological study. CSP is a sporogonic antigen
and surface membrane protein that is expressed in all
Plasmodium sporozoites. CSP has a central immunodo-
minant region comprising a short tandem repeat of
amino acid sequences containing multiple copies of the
immunodominant B-cell epitope [14]. CSP is classified
into two serotypes, VK210 [the dominant form, with
GDRA(D/A)GQPA repeats] and VK247 [the variant form,
with ANGA(G/D)(N/D)QPG repeats], which have differ-
ent sequences in the repeated region of the CSP gene. It is
known that the vivax malaria prevalent in Korea is the
VK210 type [15].
The annual parasite incidence (API) in Ganghwa
county (Figure 1A) fluctuated from 2001 to 2012 (from0.76 to 3.36) and peaked in 2007 (Figure 2A). Two
islands, Gyodongmyeon and Samsanmyeon, which con-
tain 24.5% (15.1%–30.9%) of patients with malaria
among all patients in Ganghwa with malaria, were se-
lected for the seroepidemiological study to evaluate the
CSP antigen. In Cheorwon (Figure 1B), four administra-
tive areas were selected for blood collection. The API of
Cheorwon also fluctuated during the same time period
(from 0.12 to 4.07) and peaked in 2001 (Figure 2B). The
number of patients with malaria was 9.9% (2.9%–22.5%)
in Cheorwoneup, 33.5% (20.4%–44.7%) in Dongsongeup,
12.6% (8.1%–16.7%) in Gimhwaeup, and 7.1% (0.0%–
12.7%) in Seomyeon among all patients with malaria in
Cheorwon county (Unpublished data, Korea Center for
Disease Control and Prevention).
In this study, the dormant form of CSP was expressed
and purified from Escherichia coli to produce antigen for
the detection of anti-P. vivax CSP antibody levels in the in-
habitants of Ganghwa and Cheorwon counties to evaluate
CSP antigen in comparing the local malaria prevalence.
Methods
Study area
The study was conducted in Ganghwa county of
Incheon Metropolitan city and Cheorwon county of
Gangwon province, ROK. Ganghwa county (37°31′-45 N’,
125°33′-126°2′E) contains 179 villages (administrative
village, -ri) in an area of 411 km2 that is covered with
forested hilly mountains (181 km2, 44%), agricultural
land (164 km2, 40%), building site (13 km2, 3%), and
others (52 km2, 13%). The total population of Ganghwa
county was 67,668 persons (male, 33,725; female,
38,943) living in 29,055 households in 2010 [16]. Cheor-
won county (38°05′-24 N’, 126°56′-127°24′E) contains
109 villages (administrative village, -ri) in an area of
889 km2 that is covered with forested hilly mountains
(601 km2, 67%), agricultural land (209 km2, 24%), build-
ing site (8 km2, 1%), and others (71 km2, 8%). The total
population of Ganghwa county was 49,463 persons
(male, 25,820; female, 23,643) living in 20,316 house-
holds in 2010 [17].
Blood sample collection
The study locations are shown on the map in Figure 1. All
of the study areas were near the DMZ, which is located
along the borderline of DPRK. Blood samples were col-
lected from participants residing in 32 villages among two
administrative areas in Ganghwa county of Gyeonggi
province and in 10 villages among four administrative
areas in Cheorwon county of Gangwon province. It was
conducted in November and December of 2010 and in
November and December of 2011 in two areas of ROK:
Ganghwa county of Incheon city, which contains two































Figure 1 Study areas. A, Ganghwa county; B, Cheorwon county; a, Gyodongmyeon; b, Samsanmyeon; c, Cheorwoneup; d, Dongsongeup; e,
Gimhwaeup; f, Seomyeon.
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tains 3 –eup and 1 –myeon, Cheorwoneup, Dongsongeup,
Gimhwaeup, and Seomyeon which is connected to DPRK
by land (Figure 1B). To evaluate CSP recombinant protein
as antigen for serodiagnosis, a total of 1,825 (4.77%) and

























Figure 2 Annual parasite incidence of study areas from 2001 to 20122011 from who wanted be a volunteer, respectively, from
38,288 total inhabitants in the study areas.
Blood smears were prepared for microscopic examin-
ation. Sera were separated and stored at −20°C for anti-
body analysis. Informed consent was obtained from all


























. A, Ganghwa county; B, Cheorwon county.
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Human Ethics Committee of Inha University
Microscopic examination
Thin blood films were prepared to determine the infect-
ivity of blood samples. The blood films were fixed with
methanol and stained with Giemsa stain diluted with
buffered water at pH 7.2 to emphasize the parasite inclu-
sions in the red blood cells (RBCs). The fixed monolayer
of RBCs in this procedure makes the morphological
identification of the parasite to the species level much
easier and provides greater specificity than that obtained
with thick-film examination. Thin blood films are often
preferred for routine estimation of parasitaemia because
the organisms are easier to see and count with this
method [18]. To estimate the densities of blood-stage
parasites by microscopy, it was counted the number of
asexual parasites observed relative to 200 white blood
cells (WBCs) and then multiplied the parasite:WBC ratio
by 8,000, that is, the assumed number of WBCs per
microlitre of blood [19].
Amplification of the CSP gene
To express the CSP gene, genomic DNA was extracted
from the whole blood of a patient with malaria using a
QIAamp Blood Kit (Qiagen, Hilden, Germany). Polymer-
ase chain reaction (PCR) was performed using Accu-
Power PCR PreMix (Bioneer, Daejeon, Korea), 50 ng of
purified genomic DNA, and 40 pmoles each of forward
(F1; 5′-CAC GTA GGA CAA AGT GCT AGC CG-3′)
and reverse primer (R1; 5-′ATG GAC TCC ATG CAG
TGT AA-3′). The total volume was adjusted to 50 μl
with distilled water. The thermocycler conditions were
as follows: denaturation at 94°C for 5 min; 35 cycles of
30 s at 94°C, 30 s at 55°C, and 45 s at 72°C; and finally,
incubation at 72°C for 5 min. All PCR products were an-
alyzed on a 1% agarose gel, confirmed under a UV trans-
illuminator, and purified with a NucleoSpin Extract Kit
(Macherey-Nagel, Duren, Germany).
DNA sequencing and analysis
To genotype the CSP gene of P. vivax, the PCR product
of the CSP gene was ligated into a pGEM-T Easy Vector
(Promega, Madison, WI, USA) and transformed into
E. coli DH5α. The PCR product containing E. coli DH5α
was selected on ampicillin-containing medium [20]. To
confirm the transformants, gel electrophoresis was per-
formed with EcoRI digestion products after the plasmid
was prepared with a Qiagen plasmid isolation kit accord-
ing to the protocol supplied by the manufacturer. The
CSP gene sequence was determined using an ABI
PRISM Dye Terminator Cycle Sequencing Ready Reac-
tion Kit FS (Perkin Elmer, Cambridge, MA, USA) ac-
cording to the manual supplied by the manufacturer.M13 reverse and M13 forward (−20) primers were used
in the sequencing. Nucleotide and deduced amino acid
sequences were analyzed using EditSeq and Clustal in
the MegAlign program, a multiple alignment program in
the DNASTAR package (DNASTAR, Madison, WI,
USA). The internet-based BLAST search program of the
National Center for Biotechnology Information was used
to search protein databases.
Construction of the CSP expression vector
To express the CSP gene in E. coli DH5α, a CSP gene
fragment was amplified from a blood sample that was
confirmed to be infected with the dormant type of
P. vivax as described above with the exception of the
addition of the Fex2 (5′-ggatccAAAAAGGATGGAAA
GAAAG-3′) and Rex2 (5′-aagcttGACTTTTCATTTGG
GGCA-3′) primers, which contain BamHI and HindIII
sites on their 5′ ends, respectively. The amplified PCR
products were digested with BamHI and HindIII, puri-
fied with a Qiagen gel extraction kit after being run on
an agarose gel, and then integrated into the BamHI and
HindIII cleavage sites of the pET-28a(+) expression vec-
tor (Novagen, 5,369 bp). The resulting plasmid was sub-
sequently used for the expression of a CSP-(His)6 fusion
protein in E. coli. The transformants were confirmed by
both gel electrophoresis of plasmid DNA after restric-
tion enzyme digestion with BamHI and HindIII and
DNA sequencing.
Expression and purification of recombinant CSP
Expression of the recombinant protein was induced in
E. coli DH5α with isopropyl-1-thio-β-D-galactopyranoside
(IPTG) [10]. The CSP-(His)6 fusion protein was purified
using immobilized metal ion affinity chromatography
[21]. The purification was performed under native con-
ditions according to the supplier’s protocol (Novagen).
Proteins were analyzed by sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDS-PAGE) after each
purification step.
Western blot analysis
The recombinant CSP-(His)6 fusion protein was separated
on a 12% SDS-PAGE gel and transferred to a nitrocellu-
lose membrane. After the transfer, the membrane was cut
into strips and blocked for nonspecific binding with 3%
skim milk for 12 h at 4°C. The membrane was then
washed three times for 10 min each with 0.15% Tween
20-PBS. The strips were allowed to react with sera from
patients with malaria or from uninfected individuals (di-
luted 1:100, vol/vol) for 4 h; they were then washed using
the procedure described above. The membrane was subse-
quently incubated with diluted peroxidase-conjugated goat
anti-human IgG secondary antibody (1:1,000, v/v) (Sigma)
for 3 h at room temperature. For colour development, a
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H2O2/PBS was applied to each well [22,23].
Enzyme-linked immunosorbent assay
Enzyme-linked immunosorbent assays (ELISAs) were
used to determine whether the blood samples contained
antibodies against the CSP VK210 of P. vivax. Briefly,
the capture antigen solution (50 ml, 0.5 μg/ml) was
placed on a 96-well plate (Corning, Lowell, MA, USA)
and incubated for 12 h at room temperature. The wells
were aspirated and filled with blocking buffer (1% BSA,
0.05% PBS-Tween 20) and incubated for 1 h at room
temperature. After the wells were washed with 0.05%
PBS-Tween 20 three times, human serum samples in
blocking buffer at a dilution of 1:100 (vol/vol) were
added to the wells. Four positive and four negative
control serum samples were also added to each plate.
After 2 h of incubation at room temperature, the plates
were washed with 0.05% PBS-Tween 20 three times, and
peroxidase-conjugated anti-human IgG (Sigma, 1:2,000,
vol/vol) diluted in blocking buffer was then added. The
plates were re-incubated for 1 h at room temperature.
The reaction was stopped by washing the plates as
described above. To develop the colour, 100 μl of
2.2′-azino-di-(3-ethyl-benzthiozoline-6-sulfonic acid) per-
oxidase substrate (Kirkegaard & Perry Laboratories,
Gaithersburg, MD, USA) was added, and the plates were
incubated for 30 min. Absorbance was measured at
405 nm, and the cut-off value for positivity was defined
as the mean + 3 standard deviations of the negative
control samples. Negative sera were collected from volun-
teers among the staff of the Korea National Institute of
Health (KNIH).
Calculation of the annual parasite incidence
The annual parasite incidence (API) was calculated
as the number of malaria-positive patients per 1,000
inhabitants for each of the study sites using micros-
copy: API = (number of positive slides / total number of
slides) × 1,000.
Data analysis
The differences in the positive CSP rates between 2010
and 2011 were determined by a Mann–Whitney test.
Data analyses were performed using GraphPad software
(GraphPad Software Inc., La Jolla, CA, USA). Pearson’s
correlation analysis was performed to examine the
relationship between seropositivity and the API of
P. vivax in a given year. The data were analyzed using
SPSS software, version 17.0 (SPSS Inc., Chicago, IL,
USA). A P value of <0.05 was considered statistically
significant. The correlation sizes were interpreted as
none (0.0–0.09), small (0.1–0.3), medium (0.3–0.5), or
strong (0.5–1.0) [24].Results
DNA sequence of the VK210 Korean isolate
The CSP gene that was amplified by PCR from genomic
DNA was analysed on a 1.0% agarose gel. Amplification of
the CSP gene yielded an approximately 750-bp DNA frag-
ment (Figure 3A) that, after purification, was ligated into
the pGEM-T Easy vector. The transformants were con-
firmed to contain PCR inserts by EcoRI digestion. The
plasmid containing the PCR product was named pCS210
and was used for DNA sequence analysis. DNA sequen-
cing revealed that the cloned CSP gene was 717 bp long
and comprised 239 amino acids that were identified by
DNASIS. The nonapeptide repeat unit, located between
Region I (KLKOP) and Region II (PCSVT), showed the se-
quence GD(N)R(G)AD(G/A)GQP(A)A and was repeated
18 times.
Expression and antigenicity of CSP VK210 type in E. coli
To generate the expression plasmid, the repeat region of
the CSP gene was amplified from patient genomic DNA,
digested with BamHI and HindIII, and subcloned into
the same restriction enzyme sites of expression vector
pET-28a(+) (Figure 3B). The resultant plasmid, pCS210,
contained the repeat region of the CSP gene fused to a
(His)6-tag. The recombinant plasmid pCS210 was then
transferred into E. coli DH5α. Next, 1 mM IPTG was
added to cultures of E. coli DH5α (pCS210) grown to
logarithmic phase in liquid LB plus 100-μg/ml ampicillin
to induce expression of the target protein. SDS-PAGE
followed by Coomassie blue staining showed that the
molecular weight of the CSP recombinant protein was
45 kDa under native purification conditions (Figure 4A).
The molecular weight of the target protein was twice as
large as the expected molecular weight (24 kDa), which
had been determined by DNASIS, it may affected by the
repeated region of CSP.
The antigenicity of the CSP recombinant protein was
determined by western blot. The sera of patients with
malaria reacted positively (Figure 4B). To determine the
sensitivity and specificity of the CSP recombinant pro-
tein by ELISA, the sera of patients with malaria, which
had been reserved in KNIH after collection between
2009 and 2010, were used. Sera from 15 of 51 patients
with malaria (sensitivity, 29.4%) were positive, while one
serum sample from the normal control group (n = 10),
who had never been exposed to malaria, was positive
(specificity, 90.0%) (Figure 5).
Local malaria transmission in Ganghwa
Two large islands located west of Ganghwa, Gyodongdo
island (Gyodongmyeon) and Seokmodo island (Samsan-
myeon), were also surveyed (Figure 1A). A total of 230
of 1,235 (18.62%) and 256 of 1,348 study subjects
(18.99%) showed a positive response on CSP-ELISA in
bp     M    1
CSP




Figure 3 Genetic cloning of circumsporozoite protein gene. (A) Conformation of the PCR product of the circumsporozoite protein gene of
Plasmodium vivax Korean isolate. M, Molecular size marker; lane 1, CSP gene. (B) Confirmation of circumsporozoite protein gene in Escherichia coli
DH5α by restriction enzyme digestion with BamHI and HindIII. M, Molecular size marker; lane 1; BamHI and HindIII digested plasmid; lane 2,
undigested plasmid.
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positive in microscopic examinations.
Gyodongmyeon displayed a higher positive rate in
2010 (21.01%, 196/933) than in 2011 (18.53%, 179/966).
However, Samsanmyeon had a higher positive rate in
2011 (20.12%, 77/382) than in 2010 (11.26%, 34/302).
The API for 2010 (4.28) was higher than that for 2011
(2.23). The APIs for 2010 (4.86) and 2011 (3.56) in Gyo-
dongmyeon were higher than those for 2010 (3.50) and
2011 (0.44) in Samsanmyeon. The seropositivity of CSP
in 2010 showed a strong positive linear relationship with
the APIs of 2010 and 2011 (r = 1.000, P < 0.01). However,kDa       M  1   2   3   4
CSP
A
Figure 4 Expression of circumsporozoite protein gene in E. coli. (A) Pu
agarose affinity chromatography. Lane M, Molecular weight protein marker
flow-through; lane 3, wash; lane 4, elute. (B) Western blot analysis of recom
marker; lanes 1–3, patients with malaria.the seropositivity of CSP in 2011 showed a strong nega-
tive linear relationship with the APIs of 2010 and 2011
(r = 1.000, P < 0.01) (Table 1).
Local malaria transmission in Cheorwon
A total of 101 of 590 (17.12%) and 45 of 611 (7.36%)
study subjects in Cheorwon (Figure 1B) showed a posi-
tive response on CSP-ELISA in 2010 and 2011, respect-
ively (Table 2). But there was no positive in microscopic
examinations. Interestingly, Gimhwaeup exhibited a 50%
(35/70) CSP-ELISA positive rate in 2010, but this rate
dropped to 3.08% (2/65) in 2011. In 2010, the secondkDa          M    1  2   3
CSP
B
rification of recombinant circumsporozoite protein with Ni-NTA
; lane 1, induced E. coli DH5α cell lysate with IPTG; lane 2,




















Figure 5 Antigenicity of recombinant circumsporozoite protein.
Patient, individual infected with Plasmodium vivax; Normal,
healthy volunteers.
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myeon, adjacent to the eastside of Gimhwaeup; this loca-
tion was ranked highest in 2011 (15.00%, 6/40). The
third highest positive rate in both 2010 (10.85%, 28/258)
and 2011 (6.08%, 20/329) was found in Dongsongeup,
adjacent to the west side of Gimhwaeup. The lowest
positive rate (7.94%, 15/189) occurred in Cheorwoneup,
to the far west of Cheorwon, in 2010; however, this loca-
tion had the second highest rate in 2011. In addition,
Gimhwaeup showed the highest APIs in both 2010 and
2011 (3.24 and 2.36, respectively). These results suggest
that Gimhwaeup, located in the centre of Cheorwon,
was the focus of malaria transmission during the study
period. The seropositivity of CSP in 2010 showed a
moderately positive linear relationship with the API of
2010 (r = 0.435) and strong positive relationship with the
API of 2011 (r = 0.509), but without statistical signifi-
cance (P = 0.565, P = 0.491, respectively). However, the
seropositivity of CSP in 2011 showed a strong negative
linear relationship with the APIs of 2010 (r = −0.926)
and 2011 (r = −0.931), but again without statistical sig-
nificance (P = 0.071, P = 0.069, respectively) (Table 2).Table 1 Positive rates of circumsporozoite protein and annua
Area No. of sera tested No. of posit
2010 2011 2010
Gyodongmyeon 933 966 196
Samsanmyeon 302 382 34
Total 1235 1348 230
aAPI; Annual parasite incidence.Intensity of immune responses
The mean response intensity among 101 positive samples
obtained from 590 inhabitants of Cheorwon in 2010 was
0.9186 ± 0.0472. This rate dropped to 0.7035 ± 0.0457
among 45 positive samples obtained from 611 inhabitants
of Cheorwon in 2011 (P = 0.006) (Figure 6A). However,
this rate did not change significantly in Ganghwa, increas-
ingly slightly from 0.7649 ± 0.0192 among 230 positive
samples obtained from 1,235 inhabitants in 2010 to
0.8237 ± 0.1970 among 256 positive samples obtained
from 1,348 inhabitants in 2011 (P = 0.034) (Figure 6B). It
should be noted that the study areas in Ganghwa were
islands, and malaria transmission thus might not have
been affected by foreign factors, whereas Cheorwon may
have been affected by transmission from DPRK.
A total of 632 of 3,784 inhabitants exhibited a positive
CSP response, and 625 of 632 positive cases could
be categorized by age. Group A comprised CSP-positive
inhabitants under 10 years of age who exhibited an
immune response intensity of 0.7840 ± 0.0044. Group
B comprised individuals between 11 and 20 years of
age who exhibited an immune response intensity of
0.6974 ± 0.0435. Group C comprised individuals between
21 and 30 years of age who exhibited an immune re-
sponse intensity of 0.7028 ± 0.0300. Group D comprised
individuals between 31 and 40 years of age who exhib-
ited an immune response intensity of 0.7730 ± 0.0375.
Group E comprised individuals between 41 and 50 years
of age who exhibited an immune response intensity of
0.7270 ± 0.0347. Group F comprised individuals between
51 and 60 years of age who exhibited an immune response
intensity of 0.8272 ± 0.0379. Group G comprised individ-
uals between 61 and 70 years of age who exhibited an
immune response intensity of 0.7953 ± 0.0253. Group H
comprised individuals between 71 and 80 years of age who
exhibited an immune response intensity of 0.8435 ± 0.0264.
Finally, Group I comprised individuals over 81 years of
age who exhibited an immune response intensity of
0.8166 ± 0.0409. A strong positive correlation was shown
between immune response and age (r = 0.686, P = 0.041)
(Table 3).
Discussion
Our malaria research team is interested in diagnosing
vivax malaria based on antibody detection. Althoughl parasite incidence in Ganghwa
ive sera Positive rate (%) APIa
2011 2010 2011 2010 2011
179 21.01 18.53 4.86 3.56
77 11.26 20.12 3.50 0.44
256 18.62 18.99 4.28 2.23
Table 2 Positive rates of circumsporozoite protein and annual parasite incidence in Cheorwon
Area No. of sera tested No. of positive sera Positive rate (%) APIa
2010 2011 2010 2011 2010 2011 2010 2011
Cheorwoneup 189 177 15 17 7.94 9.60 0.68 0.34
Dongsongeup 258 329 28 20 10.85 6.08 2.58 1.58
Gimhwaeup 70 65 35 2 50.00 3.08 3.24 2.36
Seomyeon 73 40 23 6 31.51 15.00 0.46 0.15
Total 590 611 101 45 17.12 7.36 1.88 1.15
aAPI; Annual parasite incidence.
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for malaria diagnosis worldwide, it has disadvantages, in-
cluding the need for trained experts, its time-consuming
nature, and its tendency to miss cases of low parasit-
aemia levels. However, antibody detection can compen-
sate for the disadvantages of microscopic examination. If
an antibody detection method is applied in the field
using a rapid diagnostic test kit, the method can be used
without rigorous training and the time required for diag-
nosis will be reduced. Furthermore, most patients with
malaria have antibodies against malaria parasites, even
those with low parasitaemia levels, and this method
can be applied on a large seroepidemiologic scale. In
this study, the CSP of the vivax malaria antigen was
used to seroepidemiologically evaluate its usefulness in
understanding malaria transmission. The survey areas,
Ganghwa and Cheorwon, are two re-emerging malarial
outbreak areas in South Korea, and both areas are
located within 10 to 15 km of the southern DMZ [8].
The incidence of malaria peaks in August after the rainy
season and declines to baseline by the end of October.
Therefore, blood collection was carried out between
November and December, when the active anopheline
population was diminished. The DMZ is a 4-km-wide,
250-km-long corridor that extends across the middle




















Figure 6 Comparison of immune responses to CSP between 2010 andallowed to enter the DMZ for more than 50 years; there-
fore, natural ecosystems and biodiversity are highly
conserved in the DMZ [25]. Outbreak areas have been
expanding yearly both south and east of the DMZ.
Outbreaks in these areas are believed to have originated
from the northern part of the DMZ. The re-emergence
of malaria is presumed to have originated not from
the immigration of infected people from the north, but
from mosquitoes infected with P. vivax that flew from
the north because human passage through the DMZ is
almost impossible (although there are some exceptions
in the Gaeseong Industrial Zone). The corridor is heavily
fortified on both sides of the buffer zones with land
mines and barbed wire fences. Therefore, it is believed
that these areas are exposed to mosquitoes. To estimate
the prevalence of malaria exposure in these high-risk
areas in Korea, CSP recombinant proteins were applied.
It is a sporogony-stage protein that exists on the
surface membrane of all plasmodium sporozoites. CSP
has a central immunodominant region comprising
short tandem repeat amino acid sequences that contain
multiple copies of the immunodominant B-cell epitope
[14]. Because it is highly immunogenic and can induce
a protective response in sporozoite-immunized experi-
mental animals and humans, CSP is being investigated




















2011. Inhabitants of (A) Cheorwon and (B) Ganghwa.
Table 3 The immune responses to CSP in inhabitants
according to age
Group Age Optical density Standard deviation
A <10 0.7840 0.0044
B 11-20 0.6974 0.0435
C 21-30 0.7028 0.0300
D 31-40 0.7730 0.0375
E 41-50 0.7270 0.0347
F 51-60 0.8272 0.0379
G 61-70 0.7953 0.0253
H 71-80 0.8435 0.0264
I 80> 0.8166 0.0409
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number of P. falciparum isolates of diverse geograph-
ical origins and of a smaller number of P. vivax isolates
have been conserved within the species [26]. Interest-
ingly, the lifespan of the CSP antibody in human beings
is within 27 days in inhabitants of Thailand and is not
boosted by additional exposure to CSP antigen, i.e.,
additional infection by anopheline mosquitoes [27].
These findings led us to consider patients with malaria
with long incubation periods who usually show malaria
onset the year following a five-month-long winter sea-
son without mosquitoes. Furthermore, the mean incu-
bation period of P. vivax has been reported to be as
long as 279 ± 41 days (range, 153–452 days) [28]. This
finding suggests that patients with these long incuba-
tion periods could display either an absent or reduced
antibody level against the CSP antigen. The percentages
of patients with short and long incubation periods were
25% and 75%, respectively [8]. However, it is possible
that the patients with short incubation periods and an
onset within 1 month after exposure to the CSP antigen
delivered via infective anopheline mosquitoes had an
elevated anti-CSP antibody level. This is why the CSP
antigen was selected among the many possible malaria
antigens. The hypothesis suggested by our malaria team
is that the API of the relevant year includes patients
with short incubation periods who were infected in the
relevant year and patients with long incubation periods
who were infected in the previous year. Therefore, the
positive anti-CSP antibody rates were compared with
the APIs for the relevant and subsequent years. The
positive CSP-ELISA rate in 2010 was related to the
2010 malaria prevalence in Ganghwa and Cheorwon.
This rate might be influenced by prevalence in patients
with short incubation periods. The positive CSP-ELISA
rate in 2010 was significantly related to the 2011 mal-
aria incidence in Ganghwa and Cheorwon. This finding
suggests that the malaria situation in the subsequentyear can be predicted by the relevant positive CSP rate,
and a portion of this rate might influence the incidence
in patients with long incubation periods. In other
words, the positive CSP rate could be considered to be
the inoculation rate of sporozoites by infective vector
mosquitoes. If a person is bitten by infective mosqui-
toes, he or she will show a positive response on CSP
ELISA. However, it is very difficult to calculate how
many individuals become patients after having been
bitten by infective mosquitoes. This number is highly
dependent on individual immune competency. Unfor-
tunately, it was failed to identify parasite-positive in-
habitants by microscopic examination of 632 CSP
antibody-positive inhabitants. In addition, none of the
CSP-positive individuals in 2010 become patients in
2011. However, the positive CSP antibody rate appar-
ently affected the outbreak in the following year. This
observation may indicate that the antibody-positive
CSP rate is closely related to the community response
rather than the individual response. However, in a pre-
liminary study, the use of a blood antigen to detect an
antibody with an indirect fluorescent antibody test
(IFAT) showed that 16.67% (4/24) of individuals with
IFAT seropositivity among inhabitants of Ganghwa
became patients with malaria in the following year
(authors’ unpublished data). In another study per-
formed in Gimpo in 1999, 16 of 125 individuals with
IFAT seropositivity (12.80%) were also positive for mal-
aria by PCR detection. Blood samples with an antibody
titer of >1:256 had a high positive rate by PCR analysis
[29]. Even if it is needed to obtain more data, the differ-
ences in PCR positive rates between CSP and IFAT
among antibody-positive cases are attributable to dif-
ferent antigens, one from the sporogony stage (CSP)
and the other from the schizogony stage (IFAT). These
differences suggest that the stage-specific antigen and
antibody detection methods should be matched. There-
fore, it is better to use liver biopsy samples to detect
parasites that are present in individuals with antibody-
positive responses. Because the CSP antigen is a
sporogony-stage antigen, it can be observed in the early
developing stage of hypnozoites, which are liver-stage
parasites. However, there are ethical and economic
problems in obtaining the liver samples necessary to
detect hypnozoites by PCR. Therefore, the positive re-
sponses on CSP antibody assays did not coincide with
the PCR responses for antigen detection that used only
blood samples.
To evaluate malaria transmission in a given geographical
region, many factors, including temperature, mosquito
density, vector capacity, climate, rainfall, and humidity,
should be considered [30]. Parasitaemia provides a
classical means of measuring malaria endemicity. How-
ever, patient incidence alone cannot provide a complete
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http://www.malariajournal.com/content/12/1/448understanding of malaria prevalence because many factors
affect the malaria prevalence in ROK, including the popu-
lation density of mosquitoes, vectorial capacity, long- to
short-incubation-patient ratio, symptomatic to asymptom-
atic patient ratio, differences in rainfall and temperature,
and immunity of the community.
Conclusions
Antibody detection using CSP-ELISA may provide useful
information regarding malaria prevalence in certain
areas and individuals. These serological methods are
useful in identifying areas that require malaria control
and evaluating the surveillance system in certain areas.
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